# GH Research Ireland

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gh-research-ireland

- Industry: Pharmaceuticals
- Headquarters: Dublin, Ireland
- Website: www.ghres.com
- Total disclosed funding: $125M
- Latest round: Series B (Apr 12, 2021)
- Investors on record: 11

## About

Based in Dublin, Ireland and founded in 2018, GH Research Ireland Limited operates as a pharmaceutical company that focuses on developing therapeutic drugs for psychiatric and neurological disorders. The company's chairman of the board was Florian Schönharting. In April 2021, GH Research Ireland Limited raised USD 125 million in series B funding from Acuta Capital Partners, Boxer Capital, RA Capital, and RTW Investments.

The company's line of products includes GH001 is an innovative drug that uses an inhaled formulation of 5-MeO-DMT which helps to treat depression and mental illness. While GH002 is an injectable formulation of 5-MeO-DMT that focuses on treating mental diseases.

GH Research Ireland Limited plans to advance GH001 into clinical development and explore additional drug delivery approaches.

## Funding rounds

- Series B, Apr 12, 2021, $125M — Verition Fund Management, Deerfield Management, RTW Investments, BVF Partners, RA Capital Management, Cormorant Asset Management, Acuta Capital Partners, Boxer Capital, Surveyor Capital, Logos Capital, Venrock Healthcare Capital Partners

## Investors

- Verition Fund Management — Series B
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series B
- RTW Investments (https://capitalatlas.ai/funds/rtw-investments) — Series B
- BVF Partners (https://capitalatlas.ai/funds/bvf-partners) — Series B
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series B
- Acuta Capital Partners (https://capitalatlas.ai/funds/acuta-capital-partners) — Series B
- Boxer Capital (https://capitalatlas.ai/funds/boxer-capital) — Series B
- Surveyor Capital — Series B
- Logos Capital (https://capitalatlas.ai/funds/logos-capital) — Series B
- Venrock Healthcare Capital Partners (https://capitalatlas.ai/funds/venrock-healthcare-capital-partners) — Series B